BeOne Medicines ONC
NASDAQ ONC
$369.06 -5.02 (-1.34%)
At close: Oct 16, 2026 · 4:00 PM EDT

BeOne Medicines (ONC) Net Equity Issued and Repurchased (2016 - 2026)

Updated

BeOne Medicines (ONC) posted Net Equity Issued and Repurchased of $11.05 million for Q2 2026, down 66.7% from $33.14 million a year earlier and down 53.7% from the prior quarter.

Analysis

BeOne Medicines (ONC) Net Equity Issued and Repurchased (2016 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Equity Issued and Repurchased at BeOne Medicines was $134.7 million, up 10.8% year-over-year; for FY2025, it came in at $196.28 million, up 332.6% from FY2024.

  • Annual Net Equity Issued and Repurchased shows a five-year compound annual growth rate of -45.9% (FY2020 to FY2025).
  • In prior years, BeOne Medicines' Net Equity Issued and Repurchased was $45.37 million in FY2024 (-18.6%), $55.71 million in FY2023 (+18.6%), $46.96 million in FY2022 (-98.6%) and $3.39 billion in FY2021 (-19.8%).
  • The Q2 2026 figure stands as the lowest quarterly Net Equity Issued and Repurchased since Q4 2024.
  • On a year-over-year basis, Net Equity Issued and Repurchased increased in five of the last eight quarters, with growth averaging 170.8%.
  • The strongest year-over-year quarter for Net Equity Issued and Repurchased in the past five years was Q2 2025, with growth of 495.7%; the weakest was Q4 2022, with a decline of 99.7%.
  • According to Business Quant data, Net Equity Issued and Repurchased for the three prior quarters was $23.88 million (Q1 2026), $19.24 million (Q4 2025) and $80.54 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 138.00 Mn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -9.00 Mn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 6.00 Mn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -346.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 BeOne Medicines 41.22 Bn 22.75 Bn 1.53 Bn 11.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.05 Mn
Mar 31, 2026 23.88 Mn
Dec 31, 2025 19.24 Mn
Sep 30, 2025 80.54 Mn
Jun 30, 2025 33.14 Mn
Mar 31, 2025 63.36 Mn
Dec 31, 2024 8.80 Mn
Sep 30, 2024 16.22 Mn
Jun 30, 2024 5.56 Mn
Mar 31, 2024 14.79 Mn
Dec 31, 2023 3.36 Mn
Sep 30, 2023 17.18 Mn
Jun 30, 2023 3.58 Mn
Mar 31, 2023 31.59 Mn
Dec 31, 2022 11.29 Mn
Sep 30, 2022 16.71 Mn
Jun 30, 2022 7.09 Mn
Mar 31, 2022 11.88 Mn
Dec 31, 2021 3.40 Bn
Sep 30, 2021 96.59 Mn
API Access

BeOne Medicines Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=ONC&period=max&api_key=YOUR_API_KEY